<VariationArchive VariationID="632731" VariationName="NM_000061.3(BTK):c.655del (p.Val219fs)" VariationType="Deletion" Accession="VCV000632731" Version="2" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2024-02-20" DateCreated="2019-06-02" MostRecentSubmission="2024-02-14">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="621658" VariationID="632731">
      <GeneList>
        <Gene Symbol="BTK" FullName="Bruton tyrosine kinase" GeneID="695" HGNC_ID="HGNC:1133" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>Xq22.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="101349450" stop="101390796" display_start="101349450" display_stop="101390796" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="100604434" stop="100641211" display_start="100604434" display_stop="100641211" Strand="-" />
          </Location>
          <OMIM>300300</OMIM>
          <Haploinsufficiency last_evaluated="2021-03-24" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=BTK">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2021-03-24" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=BTK">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_000061.3(BTK):c.655del (p.Val219fs)</Name>
      <CanonicalSPDI>NC_000023.11:101360688:CC:C</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>Xq22.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="101360689" stop="101360689" display_start="101360689" display_stop="101360689" variantLength="1" positionVCF="101360688" referenceAlleleVCF="AC" alternateAlleleVCF="A" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="100615677" stop="100615677" display_start="100615677" display_stop="100615677" variantLength="1" positionVCF="100615676" referenceAlleleVCF="AC" alternateAlleleVCF="A" />
      </Location>
      <ProteinChange>V219fs</ProteinChange>
      <ProteinChange>V253fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_128" sequenceAccession="LRG_128">
            <Expression>LRG_128:g.30536del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000061.2" sequenceAccession="NM_000061" sequenceVersion="2" change="c.655delG">
            <Expression>NM_000061.2:c.655delG</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.10" sequenceAccession="NC_000023" sequenceVersion="10" change="g.100615678del" Assembly="GRCh37">
            <Expression>NC_000023.10:g.100615678del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.11" sequenceAccession="NC_000023" sequenceVersion="11" change="g.101360690del" Assembly="GRCh38">
            <Expression>NC_000023.11:g.101360690del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_009616.1" sequenceAccession="NG_009616" sequenceVersion="1" change="g.30536del">
            <Expression>NG_009616.1:g.30536del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000061.3" sequenceAccession="NM_000061" sequenceVersion="3" change="c.655del" MANESelect="true">
            <Expression>NM_000061.3:c.655del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000052.1" sequenceAccession="NP_000052" sequenceVersion="1" change="p.Val219fs">
            <Expression>NP_000052.1:p.Val219fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001287344.2" sequenceAccession="NM_001287344" sequenceVersion="2" change="c.757del">
            <Expression>NM_001287344.2:c.757del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001274273.1" sequenceAccession="NP_001274273" sequenceVersion="1" change="p.Val253fs">
            <Expression>NP_001274273.1:p.Val253fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001287345.2" sequenceAccession="NM_001287345" sequenceVersion="2" change="c.655del">
            <Expression>NM_001287345.2:c.655del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001274274.1" sequenceAccession="NP_001274274" sequenceVersion="1" change="p.Val219fs">
            <Expression>NP_001274274.1:p.Val219fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="1569292810" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000061.3(BTK):c.655del (p.Val219fs) AND X-linked agammaglobulinemia" Accession="RCV000780073" Version="1">
        <ClassifiedConditionList TraitSetID="3110">
          <ClassifiedCondition DB="MedGen" ID="C0221026">X-linked agammaglobulinemia</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2017-12-13" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000061.3(BTK):c.655del (p.Val219fs) AND X-linked agammaglobulinemia with growth hormone deficiency" Accession="RCV003512079" Version="1">
        <ClassifiedConditionList TraitSetID="3112">
          <ClassifiedCondition DB="MedGen" ID="C0472813">X-linked agammaglobulinemia with growth hormone deficiency</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-12-28" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-12-28" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2019-06-02" MostRecentSubmission="2024-02-14">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">10887125</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">15661032</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">16160918</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">16712653</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">16862044</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">19419768</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">19904586</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">21397315</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">33042921</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">34975878</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="3112" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="2492" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Isolated growth hormone deficiency type 3</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Growth hormone deficiency with hypogammaglobulinemia</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hypogammaglobulinemia and isolated growth hormone deficiency, X-linked</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Agammaglobulinemia and isolated growth hormone deficiency, X-linked</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Fleisher syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">X-linked agammaglobulinemia with growth hormone deficiency</ElementValue>
                <XRef ID="X-linked+agammaglobulinemia+with+growth+hormone+deficiency/9484" DB="Genetic Alliance" />
                <XRef ID="234533006" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">IGHD III</ElementValue>
                <XRef Type="MIM" ID="307200" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">ISOLATED GROWTH HORMONE DEFICIENCY, TYPE III, WITH AGAMMAGLOBULINEMIA</ElementValue>
                <XRef Type="MIM" ID="307200" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300300.0030" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300300.0040" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300300.0004" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">IGHD3</ElementValue>
                <XRef Type="MIM" ID="307200" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="3921" />
                <XRef ID="3921" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="231692" DB="Orphanet" />
              <XRef ID="631" DB="Orphanet" />
              <XRef ID="C0472813" DB="MedGen" />
              <XRef ID="MONDO:0010615" DB="MONDO" />
              <XRef Type="MIM" ID="307200" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="3110" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="39" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Agammaglobulinemia, Bruton tyrosine kinase</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Agammaglobulinemia, BTK</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">BTK-deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Bruton-type agammaglobulinemia</ElementValue>
                <XRef ID="MONDO:0010421" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Bruton's agammaglobulinemia</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">AGAMMAGLOBULINEMIA, X-LINKED, TYPE 1</ElementValue>
                <XRef Type="MIM" ID="300755" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">IMMUNODEFICIENCY 1</ElementValue>
                <XRef Type="MIM" ID="300755" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">X-linked agammaglobulinemia</ElementValue>
                <XRef ID="X-linked+agammaglobulinemia/7543" DB="Genetic Alliance" />
                <XRef ID="65880007" DB="SNOMED CT" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">AGMX1</ElementValue>
                <XRef Type="MIM" ID="300755" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">IMD1</ElementValue>
                <XRef Type="MIM" ID="300755" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">XLA</ElementValue>
                <XRef Type="MIM" ID="300755" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">X-linked agammaglobulinemia (XLA) is characterized by recurrent bacterial infections in affected males in the first two years of life. Recurrent otitis is the most common infection prior to diagnosis. Conjunctivitis, sinopulmonary infections, diarrhea, and skin infections are also frequently seen. Approximately 60% of individuals with XLA are recognized as having immunodeficiency when they develop a severe, life-threatening infection such as pneumonia, empyema, meningitis, sepsis, cellulitis, or septic arthritis. S pneumoniae and H influenzae are the most common organisms found prior to diagnosis and may continue to cause sinusitis and otitis after diagnosis and the initiation of gammaglobulin substitution therapy. Severe, difficult-to-treat enteroviral infections (often manifest as dermatomyositis or chronic meningoencephalitis) can be prevented by this treatment. The prognosis for individuals with XLA has improved markedly in the last 25 years as a result of earlier diagnosis, the development of preparations of gammaglobulin that allow normal concentrations of serum IgG to be achieved, and more liberal use of antibiotics.</Attribute>
                <XRef ID="NBK1453" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="1033" />
                <XRef ID="1033" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">Neoplasm</Attribute>
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301626</ID>
                <ID Source="BookShelf">NBK1453</ID>
              </Citation>
              <XRef ID="229717" DB="Orphanet" />
              <XRef ID="47" DB="Orphanet" />
              <XRef ID="C0221026" DB="MedGen" />
              <XRef ID="MONDO:0010421" DB="MONDO" />
              <XRef Type="MIM" ID="300755" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1793713" SubmissionDate="2019-04-24" DateLastUpdated="2019-06-02" DateCreated="2019-06-02">
        <ClinVarSubmissionID localKey="NM_000061.2:c.655delG|MedGen:C0221026" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000917096" DateUpdated="2019-06-02" DateCreated="2019-06-02" Type="SCV" Version="1" SubmitterName="Women's Health and Genetics/Laboratory Corporation of America, LabCorp" OrgID="500026" OrganizationCategory="laboratory" OrgAbbreviation="WHG-LC" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2017-12-13">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">21397315</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">19904586</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">10887125</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">16712653</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">16160918</ID>
          </Citation>
          <Comment>Variant summary: The BTK c.655delG (p.Val219LeufsX10) variant results in a premature termination codon, predicted to cause a truncated or absent BTK protein due to nonsense mediated decay, which are commonly known mechanisms for disease. Truncations downstream of this position have been classified as pathogenic by our laboratory (e.g., p.Asp239fsX38 and p.Gln260X). One in silico tool predicts a damaging outcome for this variant. This variant is absent in 178855 control chromosomes, but has been identified in several male patients with X-linked agammaglobulinemia and severely reduced BTK expression in B-cell lineages. Taken together, this variant is classified as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">LabCorp Variant Classification Summary - May 2015</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/rtxspsnt/labcorp_variant_classification_method_-_may_2015.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="BTK" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000061.2:c.655delG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">X-linked agammaglobulinemia</ElementValue>
            </Name>
            <XRef DB="MedGen" ID="C0221026" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB5494893</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7984491" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2024-02-14">
        <ClinVarSubmissionID localKey="4975773|MedGen:C0472813" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004300174" DateUpdated="2024-02-14" DateCreated="2024-02-14" Type="SCV" Version="1" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-12-28">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">15661032</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">16862044</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">19419768</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">10887125</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">33042921</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">34975878</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Val219Leufs*10) in the BTK gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in BTK are known to be pathogenic (PMID: 15661032, 16862044, 19419768). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with X-linked agammaglobulinemia (PMID: 10887125, 33042921, 34975878). This variant is also known as deletion of G787, c.757del (p.Val253Leufs*10). ClinVar contains an entry for this variant (Variation ID: 632731). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="BTK" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000023.10:g.100615677del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0472813" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14200283</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="7984491" TraitType="Disease" MappingType="XRef" MappingValue="C0472813" MappingRef="MedGen">
        <MedGen CUI="C0472813" Name="X-linked agammaglobulinemia with growth hormone deficiency" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1793713" TraitType="Disease" MappingType="Name" MappingValue="X-linked agammaglobulinemia" MappingRef="Preferred">
        <MedGen CUI="C0221026" Name="X-linked agammaglobulinemia" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

